AIM2 and atherosclerosis: Mice deficient in AIM2 exhibited smaller and more stable atherosclerotic plaques despite carrying the JAK2 mutation, indicating that AIM2 contributes to the localized vascular inflammation seen in atherosclerosis while being systemically fueled by the aging-associated CHIP environment [25].